Abhimanyu Sud
Biographic Data
| ID | 1741946 |
|---|---|
| NAME | Abhimanyu Sud |
| GIVEN NAMES | Abhimanyu |
| FAMILY NAME | Sud |
| SIGNATURE | SUD A |
| AFFILIATIONS | University of Toronto |
| ORCID | 0000-0001-8354-6153 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 21 |
| AUTHOR COUNT | 10 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Knowing Otherwise”
The COVID-19 pandemic was a time of significant crisis for most Canadians. For those living with chronic pain, it was a disproportionately challenging time. There have been calls for researchers to address the experiences of chronic pain during the time of pandemic, including for those who also struggle with systemic and structural marginalization. The purpose of this study was to highlight the experiences of people living with chronic pain and p…
From Enthusiasm to Concern and From Top-Down to Bottom-Up
The French Model of opioid use disorder care is frequently cited to advocate for policy responses to the opioid crisis. Prior research reveals a disproportionate emphasis in such citations on federal regulatory changes, raising concerns about overly narrow interpretations and potential missed opportunities for evidence-informed policymaking. We aimed to analyze how the French Model has been used to construct policy responses to the opioid crisis …
An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions
BACKGROUND: Opioid use disorder (OUD) and opioid-related harms are current health priorities in many high-income countries such as Canada. Opioid agonist therapy (OAT) is an effective evidence-based treatment for OUD, but access is often limited. AIMS: To describe and compare OUD treatment policies across nine international jurisdictions, and to understand how they are situated within their primary care and health systems. METHODS: Using policy d…
Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
Health system strengthening with a focus on improvements in primary care prescriber supply, coverage, and coordination are likely higher yield policy complements to relaxing buprenorphine regulation. Such an approach would better prepare the US to adapt to ongoing dynamics and uncertainties in the opioid crisis and to optimize the already relatively high levels of buprenorphine prescribing
Education as drug policy
BACKGROUND: Continuing professional development (CPD) for opioid agonist therapy (OAT) has been identified as a key health policy strategy to improve care for people living with opioid use disorder (OUD) and to address rising opioid-related harms. To design and deliver effective CPD programs, there is a need to clarify how they work within complex health system and policy contexts. This review synthesizes the literature on OAT CPD programs and ed…
Permissive regulation
Suboxone (buprenorphine-naloxone) is an opioid product approved in the US and Canada for the treatment of opioid use disorder. The drug is considered an important response to the opioid overdose epidemic with consistent calls for wider prescribing and deregulation. The history of Suboxone regulation in Canada has not been critically examined. Part of the rationale for doing so stems from the US regulatory experience, with documented irregularitie…
Mal/adaptations
BACKGROUND: Opioid agonist therapy (OAT) has been severely disrupted by the COVID-19 pandemic. The risks of opioid withdrawal, overdose, and diversion have increased, so there is an urgent need to adapt OAT to best support people who use drugs (PWUD). This review examines the views and experiences of PWUD, health care providers, and health system administrators on OAT during major disruptions to medical care to inform appropriate health system re…
Chronic Pain and Opioid Prescribing
Clinically focused interventions for people living with pain, such as health professional education, clinical decision support systems, prescription drug monitoring programs, and multidisciplinary care to support opioid tapering, have all been promoted as important solutions to the North American opioid crisis. Yet none have so far delivered substantive beneficial opioid-related population health outcomes. In fact, while total opioid prescribing …
Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction
Bibliometric analyses of systematic reviews offer unique opportunities to explore the character of specific scientific fields. In this time series-based analysis, dynamics of multidisciplinary care for chronic pain and opioid prescribing are analyzed over a forty-four year time span. Three distinct periods are identified, each defined by distinct research areas, as well as priorities regarding the use of opioids and the appropriate management of …
A critical content analysis of media reporting on opioids
The social construction of the opioid epidemic polarizes individuals as good or bad with little attention paid to underlying institutional interests both in the creation of the problem or in the solutions that are proposed. We show that as concerns about harms from opioids become more pronounced, the narrative shifts to home in on illicit street-use with a corresponding uptake of stigmatizing references to so-called addicts. Concurrently, most re…
A critical content analysis of media reporting on opioids
The social construction of the opioid epidemic polarizes individuals as good or bad with little attention paid to underlying institutional interests both in the creation of the problem or in the solutions that are proposed. We show that as concerns about harms from opioids become more pronounced, the narrative shifts to home in on illicit street-use with a corresponding uptake of stigmatizing references to so-called addicts. Concurrently, most re…
A critical content analysis of media reporting on opioids
The social construction of the opioid epidemic polarizes individuals as good or bad with little attention paid to underlying institutional interests both in the creation of the problem or in the solutions that are proposed. We show that as concerns about harms from opioids become more pronounced, the narrative shifts to home in on illicit street-use with a corresponding uptake of stigmatizing references to so-called addicts. Concurrently, most re…
Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction
Bibliometric analyses of systematic reviews offer unique opportunities to explore the character of specific scientific fields. In this time series-based analysis, dynamics of multidisciplinary care for chronic pain and opioid prescribing are analyzed over a forty-four year time span. Three distinct periods are identified, each defined by distinct research areas, as well as priorities regarding the use of opioids and the appropriate management of …
Education as drug policy
BACKGROUND: Continuing professional development (CPD) for opioid agonist therapy (OAT) has been identified as a key health policy strategy to improve care for people living with opioid use disorder (OUD) and to address rising opioid-related harms. To design and deliver effective CPD programs, there is a need to clarify how they work within complex health system and policy contexts. This review synthesizes the literature on OAT CPD programs and ed…
Permissive regulation
Suboxone (buprenorphine-naloxone) is an opioid product approved in the US and Canada for the treatment of opioid use disorder. The drug is considered an important response to the opioid overdose epidemic with consistent calls for wider prescribing and deregulation. The history of Suboxone regulation in Canada has not been critically examined. Part of the rationale for doing so stems from the US regulatory experience, with documented irregularitie…
Mal/adaptations
BACKGROUND: Opioid agonist therapy (OAT) has been severely disrupted by the COVID-19 pandemic. The risks of opioid withdrawal, overdose, and diversion have increased, so there is an urgent need to adapt OAT to best support people who use drugs (PWUD). This review examines the views and experiences of PWUD, health care providers, and health system administrators on OAT during major disruptions to medical care to inform appropriate health system re…
Chronic Pain and Opioid Prescribing
Clinically focused interventions for people living with pain, such as health professional education, clinical decision support systems, prescription drug monitoring programs, and multidisciplinary care to support opioid tapering, have all been promoted as important solutions to the North American opioid crisis. Yet none have so far delivered substantive beneficial opioid-related population health outcomes. In fact, while total opioid prescribing …
Buprenorphine deregulation as an opioid crisis policy response - A comparative analysis between France and the United States
Health system strengthening with a focus on improvements in primary care prescriber supply, coverage, and coordination are likely higher yield policy complements to relaxing buprenorphine regulation. Such an approach would better prepare the US to adapt to ongoing dynamics and uncertainties in the opioid crisis and to optimize the already relatively high levels of buprenorphine prescribing
An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions
BACKGROUND: Opioid use disorder (OUD) and opioid-related harms are current health priorities in many high-income countries such as Canada. Opioid agonist therapy (OAT) is an effective evidence-based treatment for OUD, but access is often limited. AIMS: To describe and compare OUD treatment policies across nine international jurisdictions, and to understand how they are situated within their primary care and health systems. METHODS: Using policy d…
From Enthusiasm to Concern and From Top-Down to Bottom-Up
The French Model of opioid use disorder care is frequently cited to advocate for policy responses to the opioid crisis. Prior research reveals a disproportionate emphasis in such citations on federal regulatory changes, raising concerns about overly narrow interpretations and potential missed opportunities for evidence-informed policymaking. We aimed to analyze how the French Model has been used to construct policy responses to the opioid crisis …
Knowing Otherwise”
The COVID-19 pandemic was a time of significant crisis for most Canadians. For those living with chronic pain, it was a disproportionately challenging time. There have been calls for researchers to address the experiences of chronic pain during the time of pandemic, including for those who also struggle with systemic and structural marginalization. The purpose of this study was to highlight the experiences of people living with chronic pain and p…
Medicine (7 works) · Opioid Use Disorder Treatment (7 works) · Opioid (6 works) · Political science (5 works) · Substance Abuse Treatment and Outcomes (5 works) · Health care (4 works) · Business (3 works) · Economics (3 works) · Health Policy Implementation Science (3 works) · HIV, Drug Use, Sexual Risk (3 works)